Based on ratings from 3 stock analysts, the Butterfly Network, Inc. stock price is expected to decrease by 1.22% in 12 months. This is calculated by using the average 12-month stock price forecast for Butterfly Network, Inc.. The lowest target is $3 and the highest is $3.75. Please note analyst price targets are not guaranteed and could be missed completely.
About 3 Wall Street analysts have assignedBFLY 3 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Butterfly Network, Inc. to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BFLY. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BFLY.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Lake Street | Buy | $3 | Initiates | Sep 10, 2024 |
Danielle Antalffy UBS | Neutral | $2.25 | Initiates | Mar 29, 2023 |
Suraj Kalia Oppenheimer | Outperform | $4.5 | Initiates | Nov 29, 2022 |
Neil Chatterji B. Riley Securities | Buy | $9.5 | Initiates | Oct 4, 2022 |
Matthew Taylor UBS | Neutral | $7 | Initiates | Dec 17, 2021 |
Cowen & Co. | Outperform | Initiates | Jun 21, 2021 |
When did it IPO
2020
Staff Count
225
Country
United States
Sector/Industry
Healthcare/Medical Devices
CEO
Mr. Joseph M. DeVivo
Market Cap
$701.0M
In 2023, BFLY generated $65.9M in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BFLY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - As of Nov. 25, 2024, three health care stocks may signal caution for momentum-focused investors.
Why It Matters - Warning signals in momentum stocks can indicate potential declines, prompting investors to reassess risk and consider reallocating their portfolios to avoid losses.
Summary - Butterfly Network (NYSE: BFLY) will present at the BTIG Digital Health Forum on November 25, 2024, featuring CEO Joseph DeVivo and Executive Heather Getz in a fireside chat.
Why It Matters - Butterfly Network's participation in the BTIG Digital Health Forum highlights its focus on innovation, potentially boosting investor confidence and interest in its growth prospects.
Summary - Butterfly Network, Inc. (NYSE: BFLY) will participate in the Canaccord Genuity MedTech Forum in NYC on November 21, 2024, with CEO Joseph DeVivo and EVP Heather Getz attending.
Why It Matters - Butterfly Network's participation in a prominent MedTech forum highlights its strategic positioning and potential for growth in the digital health sector, influencing investor sentiment and stock performance.
Summary - Butterfly Network's iQ3 handheld ultrasound device won the Best Medical Technology Award at the 2024 Prix Galien USA Awards, highlighting its innovation in portable ultrasound technology.
Why It Matters - Butterfly Network's award for its iQ3 ultrasound device enhances its reputation, potentially boosting sales and investor confidence in growth prospects and market leadership.
Summary - Butterfly Network, Inc. (NYSE:BFLY) will hold its Q3 2024 Earnings Conference Call on November 1, 2024, at 8:00 AM ET, featuring key executives and analysts.
Why It Matters - The Q3 earnings call will provide insights into Butterfly Network's financial performance, operational updates, and future projections, influencing investor sentiment and stock valuation.
Summary - Butterfly Network (NYSE: BFLY) reported Q3 2024 financial results, marking its fifth consecutive quarter of performance updates. The company focuses on portable ultrasound technology.
Why It Matters - Butterfly Network's fifth consecutive quarter of positive results indicates strong growth and operational stability, potentially boosting investor confidence and stock performance.